PlanetRx: Drugs & Perfume.com
Executive Summary
Although only six-months old, the cyber drugstore industry has generated considerable publicity and made a big impression on investors. Three major players--PlanetRx.com., drugstore.com & Soma.com-- have emerged thus far, and are engaged in a furious battle to quickly gain market share. The first major hurdle that these companies must clear is signing on third party payers, many of which own or have exclusive relationships with mail order prescription services. But the biggest challenge facing PlanetRx and its competitors is to establish themselves as partners in Web-based networks which link them with providers, third party payers and other health care influencers.
You may also be interested in...
New EU Approvals
The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add two new products, including Ryzneuta, Evive Biotechnology's treatment for chemotherapy-induced neutropenia.
Pair Of Deaths Linked To Recalled Vyaire Medical Respiratory Devices
The US FDA has labelled a recall of more than 6 million Airlife respiratory support devices class I. The recall covers devices manufactured in 2017 or earlier that can fail to provide adequate ventilation.
Over The Counter 2 Apr 2024: Analyzing The Spin-Out Trend In Consumer Health, With HBW’s Malcolm Spicer And Tom Gallen
In this episode, HBW Insight’s Europe and US editors bring their expertise to bear on the current the trend towards standalone OTC companies in global consumer health. We look at four major players: Haleon, which separated from GSK almost two years ago; Kenvue, soon to celebrate its first anniversary as a new company; Sanofi Consumer Healthcare, which is poised to split from its pharma parent; and Bayer, which has decided to buck the trend, holding on to its consumer health division. We discuss some of the advantages of becoming a standalone company, for example in leaning into a wider concept of self-care.